Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms

Gastroenterology
C M WilcoxS E Thompson

Abstract

The best initial treatment of human immunodeficiency virus (HIV)-infected patients with esophageal symptoms is unknown. The outcome, including safety and cost-effectiveness, of fluconazole compared with endoscopy as a treatment strategy for HIV-infected patients with new-onset esophageal symptoms was evaluated. During a 53-month period, 134 HIV-infected patients with esophageal symptoms were randomized prospectively to groups receiving either standard doses of fluconazole or endoscopy. Among the 68 patients in the fluconazole group, a complete symptomatic response was observed in 56 patients (82%), usually within 1 week. The most common endoscopic findings in the 66 patients in the endoscopy group included Candida esophagitis alone in 42 patients (64%) and ulcerative esophagitis in 10 patients (15%). Patients responding to empirical antifungal therapy or who had Candida esophagitis alone at endoscopy were less like to have severe symptoms (P = 0.027) or odynophagia as the only symptom (P < 0.001) but more frequently had odynophagia and dysphagia (P = 0.007) and thrush (P = 0.002). Empirical fluconazole was cost-effective, saving $738.16 per patient. Empirical oral antifungal therapy with fluconazole is highly efficacious, safe,...Continue Reading

Citations

Jun 1, 1997·Alimentary Pharmacology & Therapeutics·C M Wilcox, K E Mönkemüller
Aug 29, 2003·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Syed Ali Zaidi, Joseph S Cervia
Sep 23, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michele I Morris, Mark Villmann
Dec 17, 2008·Digestive Diseases and Sciences·Sharad SharmaNicolas Jabbour
Jul 6, 2013·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·N AsayamaN Uemura
Mar 7, 2009·World Journal of Gastroenterology : WJG·Ana Luiza Werneck-Silva, Ivete Bedin Prado
Dec 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Mar 11, 2005·Expert Opinion on Emerging Drugs·Anne Chen, Jack D Sobel
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Neelima Reddy, C Mel Wilcox
Jun 6, 2009·Tropical Medicine & International Health : TM & IH·Rony ZachariahAnthony D Harries
Sep 14, 2000·Comprehensive Therapy·K E Mönkemüller, C M Wilcox
Sep 22, 1998·The Journal of the Association of Nurses in AIDS Care : JANAC·C J Thomas
Jun 1, 1997·Gastroenterology Clinics of North America·F Clayton, C H Clayton
Jun 1, 1997·Gastroenterology Clinics of North America·C M Noyer, D Simon
Jun 27, 2000·Gastroenterology·S Banerjee, J T LaMont
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.